Literature DB >> 1993708

Asn-linked oligosaccharide-dependent interaction between laminin and gp120/140. An alpha 6/beta 1 integrin.

R Chammas1, S S Veiga, S Line, P Potocnjak, R R Brentani.   

Abstract

Receptor-mediated recognition and adhesion to laminin, a specific glycoprotein from basement membranes, exert an important role in many biological phenomena. Studying cell surface proteins of B16-F10, a metastatic murine melanoma cell line, we identified a 120-140 kDa glycoprotein (gp120/140) that binds laminin. This glycoprotein was recognized by a polyclonal antibody raised against the human fibronectin receptor beta 1-integrin chain, as well as immunoprecipitated by an anti-alpha 6 chain (monoclonal antibody GoH3), characterizing it as an alpha 6/beta 1-integrin. Its binding to laminin was specific and displayed moderate affinity, as its apparent dissociation constant was 18 nM. To characterize the influence of carbohydrate moieties on the laminin-gp120/140 interaction, metaperiodate oxidation, metabolic inhibition of glycosylation, and enzymatic deglycosylation studies were performed. Our results indicate that gp120/140 Asn-linked oligosaccharides play a part in this interaction. Reciprocally, both metaperiodate and N-glycanase treatment of native laminin reduced its binding to gp120/140, characterizing the latter as a lectin-like molecule. These results point to glycosylation processes as a possible mechanism for variable binding specificity profiles among integrins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993708

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Presence of a laminin-binding chondroitin sulfate proteoglycan at the cell surface of a human melanoma cell Mel-85.

Authors:  M C Elias; S S Veiga; W Gremski; M A Porcionatto; H B Nader; R R Brentani
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

2.  N-glycosylation of the I-like domain of beta1 integrin is essential for beta1 integrin expression and biological function: identification of the minimal N-glycosylation requirement for alpha5beta1.

Authors:  Tomoya Isaji; Yuya Sato; Tomohiko Fukuda; Jianguo Gu
Journal:  J Biol Chem       Date:  2009-03-04       Impact factor: 5.157

3.  Isolation of a laminin-binding protein from the protozoan parasite Leishmania donovani that may mediate cell adhesion.

Authors:  A Ghosh; K Bandyopadhyay; L Kole; P K Das
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

Review 4.  Perspectives on the significance of altered glycosylation of glycoproteins in cancer.

Authors:  Y J Kim; A Varki
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

5.  Sialylation of terminal saccharides of glycoconjugates expressed by murine molar tooth germs developing in vitro and in vivo.

Authors:  A K Jowett; S J Kimber; M W Ferguson
Journal:  J Anat       Date:  1994-08       Impact factor: 2.610

6.  Functionally distinct roles for glycosylation of alpha and beta integrin chains in cell-matrix interactions.

Authors:  R Chammas; S S Veiga; L R Travassos; R R Brentani
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

7.  Identification of a Treponema pallidum laminin-binding protein.

Authors:  Caroline E Cameron
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

8.  Comprehensive proteomic analysis of nonintegrin laminin receptor interacting proteins.

Authors:  Lisa Venticinque; Daniel Meruelo
Journal:  J Proteome Res       Date:  2012-08-29       Impact factor: 4.466

9.  Mutations in and near the second calcium-binding domain of integrin alphaIIb affect the structure and function of integrin alphaIIbbeta3.

Authors:  Susan Gidwitz; Brenda Temple; Gilbert C White
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

10.  RTX cytotoxins recognize beta2 integrin receptors through N-linked oligosaccharides.

Authors:  Jana Morova; Radim Osicka; Jiri Masin; Peter Sebo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.